• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Thursday, September 11, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

Study finds obese patients don’t need to lose weight before total joint replacement

Bioengineer by Bioengineer
July 19, 2017
in Health
Reading Time: 3 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

Credit: Bryan Goodchild, UMass Medical School

There's good news from UMass Medical School for overweight people with painfully arthritic hips and knees: A new study finds that obese patients who underwent knee or hip replacement surgery reported virtually the same pain relief and improved function as normal-weight joint replacement patients six months after surgery.

"Our data shows it's not necessary to ask patients to lose weight prior to surgery," said Wenjun Li, PhD, associate professor of medicine and lead author on the study. "It's challenging for a patient who is severely overweight and suffering in pain to exercise–often they just can't do it. Our evidence showed that severe morbidly obese patients can benefit almost equally as normal weight patients in pain relief and gains in physical function."

The aim of the study, published July 19 in the Journal of Bone and Joint Surgery, was to evaluate the extent of pain relief and functional improvement in total joint replacement patients with various levels of obesity. The researchers concluded that while obesity is associated with a greater risk of early complications, obesity in itself should not be a deterrent to undergoing total joint replacement to relieve symptoms.

Prior research has documented that obesity is associated with a small, but increased likelihood of infection after total knee replacement, which may discourage obese patients from having surgery. "However, in this paper we report that obese patients have comparable pain relief and functional outcomes after surgery," said Patricia Franklin, MD, MBA, MPH, professor of orthopedics & physical rehabilitation. "Patients should know that these benefits may outweigh risks."

Dr. Franklin is principal investigator of the Function and Outcomes Research for Comparative Effectiveness in Total Joint Replacement (FORCE-TJR) program from the federal Agency for Healthcare Research and Quality. She co-authored the paper with David Ayers, MD, the Arthur M. Pappas, MD, Chair in Orthopedics and chair and professor of orthopedics & physical rehabilitation; Jeroan J. Allison, MD, MS,, vice chair and professor of quantitative health sciences; and colleagues at Hartford Hospital and Geisinger Health Center.

Preoperative and 6-month postoperative data on function, joint pain and body mass index (BMI) from a national sample of 2,040 patients who had undergone total hip replacement and 2,964 who had undergone total knee replacement from May 2011 to March 2013 was collected. Preoperative and postoperative function and pain were evaluated according to BMI status, defined as under or of normal weight, overweight, obese, severely obese, or morbidly obese. A greater obesity level was associated with worse pain at baseline but greater postoperative pain relief, with average postoperative pain scores at six months similar across the BMI levels.

"This surprised us a little bit. Past analysis showed that obesity is associated with outcomes to some degree, but here we see the magnitude is so small it won't make much difference, and severely obese patients can benefit a lot from the surgery," said Dr. Li. "Patients who can lose weight should, but we acknowledge many people can't, or it will take a long time during which their joints will worsen. If they can get the surgery earlier, once function is restored they can better address obesity."

"Losing weight by making appropriate dietary changes and increasing the calories burned each day through water exercise programs and other aerobic, non-weight bearing activities is always appropriate to decrease the risk of complications for overweight patients," said FORCE-TJR co-investigator Dr. Ayers. "This manuscript adds to our collective knowledge regarding the risk benefit ratio of total joint replacement surgery in obese patients. The debate will continue in the morbidly obese patients with BMI over 40, and the super obese with a BMI over 50, regarding what steps can and should be taken to lower the risks before these elective surgical procedures."

Funded by a $12 million grant, the FORCE-TJR research program has developed a national database of surgical results and patient-reported outcomes from more than 30,000 patients. FORCE-TJR is unique in quantifying patient reported pain and function after surgery in order to assess multiple factors associated with the best results.

"Other registries primarily evaluate implant longevity," said Franklin. "Thus FORCE-TJR has taken the lead in evaluating patient factors and outcomes."

###

Media Contact

Sarah Willey
[email protected]
774-284-0186
@UMassMedical

http://www.umassmed.edu

Share12Tweet7Share2ShareShareShare1

Related Posts

Smart ROS Nanoplatform Boosts Targeted Cancer Therapy

September 11, 2025

Creating AI Companions for Caregiver Role Transitions

September 11, 2025

New Guidelines for Anti-VEGF Therapy in Diabetic Retinopathy

September 11, 2025

Ether-Lipid Buildup Fuels Liver Cancer Progression

September 11, 2025
Please login to join discussion

POPULAR NEWS

  • blank

    Breakthrough in Computer Hardware Advances Solves Complex Optimization Challenges

    152 shares
    Share 61 Tweet 38
  • New Drug Formulation Transforms Intravenous Treatments into Rapid Injections

    116 shares
    Share 46 Tweet 29
  • Physicists Develop Visible Time Crystal for the First Time

    63 shares
    Share 25 Tweet 16
  • First Confirmed Human Mpox Clade Ib Case China

    56 shares
    Share 22 Tweet 14

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Complete Chloroplast Genome of Cyathea delgadii Revealed

Smart ROS Nanoplatform Boosts Targeted Cancer Therapy

Creating AI Companions for Caregiver Role Transitions

  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.